RARA CRAFT DATABASE for FDA Medical Devices
PMAP150001

FDA DEVICE FACTS

MINIMED 630G SYSTEM WITH SMARTGUARD(TM)

Medtronic Minimed

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEAugust 10, 2016PRODUCT CODEOZO

Indications for use

MiniMed 630G System with SmartGuard The MiniMed 630G System with SmartGuard™ is intended for continuous delivery of basal insulin (at user selected rates) and administration of insulin boluses (in user selectable amounts) for the management of diabetes mellitus in persons, sixteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 630G system includes SmartGuard™, which can be programmed to temporarily suspend delivery of insulin for up to two hours when the sensor glucose value falls below a predefined threshold value.

The MiniMed 630G System with SmartGuard™ consists of the following devices: MiniMed 630G Insulin Pump, Enlite® Sensor, One-press serter, Guardian® Link Transmitter System, CareLink® USB, Bayer’s CONTOUR ® NEXT LINK 2.4 Wireless Meter, and Bayer’s CONTOUR® NEXT Test Strips. The system requires a prescription.

The MiniMed 630G System with SmartGuard™ is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a finger stick may be required. All therapy adjustments should be based on measurements obtained using a home glucose monitor and not on values provided by the MiniMed 630G system.

The MiniMed 630G System with SmartGuard™ is not intended to be used directly for preventing or treating hypoglycemia but to suspend insulin delivery when the user is unable to respond to the SmartGuard™ Suspend on low alarm to take measures to prevent or treat hypoglycemia themselves. Therapy to prevent or treat hypoglycemia should be administered according to the recommendations of the user’s healthcare provider.

Enlite® Sensor The Enlite® Sensor is intended for use with Medtronic MiniMed Insulin pump (MMT-1715). It continuously monitors glucose levels in persons with diabetes.

One-press Serter The One-press Serter is used as an aid for inserting the Enlite sensor. It is indicated as a single-patient use device and it is not intended for multiple-patient use.

Guardian® Link Transmitter System The Medtronic MiniMed Guardian Link Transmitter System is indicated for use as a component of select Medtronic continuous glucose monitoring and sensor-enabled pump systems. It processes, stores and transmits glucose sensor values to data collection and display devices. The Guardian Link Transmitter System is not intended to function as a stand-alone device and is for single-patient use. The Guardian Link Transmitter System includes the Guardian Link Transmitter (MMT-7763), charger (MMT-7715), watertight tester (MMT-7726), and One-press serter (MMT-7512).

CareLink® USB The Medtronic CareLink® USB is indicated for use by patients at home, and clinicians in a medical office setting, to facilitate communication between MiniMed 630G insulin pump and a personal computer. The computer must use Medtronic diabetic therapy management software.

Bayer CONTOUR® NEXT Link 2.4 Wireless Blood Glucose Glucose Monitoring System The CONTOUR® NEXT Link 2.4 Wireless Blood Glucose Monitoring System is an over the counter (OTC) and/or prescription device utilized by persons with diabetes in home settings for the measurement of glucose in whole blood, and is for single-patient use only. The CONTOUR® NEXT Link 2.4 wireless blood glucose monitoring system is indicated for use with fresh capillary whole blood samples (drawn from the fingertip or palm only). The CONTOUR® NEXT Link 2.4 Blood Glucose Meter can wirelessly connect to the MiniMed 630G pump through the use of radio frequency communication. The meter can transmit glucose values, be used as a remote control to facilitate delivery of a bolus of insulin from the insulin pump, and facilitate transfer of information from the pump to the Medtronic MiniMed data management software. The CONTOUR® NEXT Link 2.4 Wireless Blood Glucose Monitoring System is not intended for the diagnosis of or screening for diabetes mellitus and is not intended for use on neonates.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026